Nu-Med Plus, Inc. (NUMD) stock
NUMDOTCGold and Silver OresFiscal year ends December 31
$0.01−0.00 (-8.16%)
Close on Oct 19, 2026Market cap $601.55KP/E –Yield –
Nu-Med Plus shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Nu-Med Plus's shares outstanding was 84M at Jun 30, 2026. For fiscal 2025 it was 84M, up 0.0% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is 84M in fiscal 2024.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 84M | 0.0% |
| FY2024 | Dec 31, 2024 | 84M | +2.3% |
| FY2023 | Dec 31, 2023 | 82M | +2.2% |
| FY2022 | Dec 31, 2022 | 80M | +9.0% |
| FY2021 | Dec 31, 2021 | 73M | +34.6% |
| FY2020 | Dec 31, 2020 | 55M | +19.7% |
| FY2019 | Dec 31, 2019 | 46M | +9.0% |
| FY2018 | Dec 31, 2018 | 42M | -41.9% |
| FY2017 | Dec 31, 2017 | 72M | -4.2% |
| FY2016 | Dec 31, 2016 | 75M | +112.0% |
| FY2015 | Dec 31, 2015 | 35M | +8.0% |
| FY2014 | Dec 31, 2014 | 33M | +17.9% |
| FY2013 | Dec 31, 2013 | 28M | +22.9% |
| FY2012 | Dec 31, 2012 | 23M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 84M | 0.0% |
| Q1 FY2026 | Mar 31, 2026 | 84M | 0.0% |
| Q4 FY2025 | Dec 31, 2025 | 84M | 0.0% |
| Q3 FY2025 | Sep 30, 2025 | 84M | 0.0% |
| Q2 FY2025 | Jun 30, 2025 | 84M | 0.0% |
| Q1 FY2025 | Mar 31, 2025 | 84M | 0.0% |
| Q4 FY2024 | Dec 31, 2024 | 84M | +1.1% |
| Q3 FY2024 | Sep 30, 2024 | 84M | +2.7% |
| Q2 FY2024 | Jun 30, 2024 | 84M | +2.7% |
| Q1 FY2024 | Mar 31, 2024 | 84M | +2.7% |
| Q4 FY2023 | Dec 31, 2023 | 83M | +1.6% |
| Q3 FY2023 | Sep 30, 2023 | 81M | +2.0% |
| Q2 FY2023 | Jun 30, 2023 | 81M | +2.5% |
| Q1 FY2023 | Mar 31, 2023 | 81M | +2.5% |
| Q4 FY2022 | Dec 31, 2022 | 81M | +46.5% |
| Q3 FY2022 | Sep 30, 2022 | 80M | +0.5% |
| Q2 FY2022 | Jun 30, 2022 | 79M | 0.0% |
| Q1 FY2022 | Mar 31, 2022 | 79M | +0.1% |
| Q4 FY2021 | Dec 31, 2021 | 56M | -23.6% |
| Q3 FY2021 | Sep 30, 2021 | 79M | +57.9% |
| Q2 FY2021 | Jun 30, 2021 | 79M | +67.6% |
| Q1 FY2021 | Mar 31, 2021 | 79M | +70.3% |
| Q4 FY2020 | Dec 31, 2020 | 73M | +58.2% |
| Q3 FY2020 | Sep 30, 2020 | 50M | +9.4% |
| Q2 FY2020 | Jun 30, 2020 | 47M | +4.4% |
| Q1 FY2020 | Mar 31, 2020 | 47M | +12.3% |
| Q4 FY2019 | Dec 31, 2019 | 46M | -12.6% |
| Q3 FY2019 | Sep 30, 2019 | 46M | +17.7% |
| Q2 FY2019 | Jun 30, 2019 | 45M | +19.9% |
| Q1 FY2019 | Mar 31, 2019 | 41M | +10.4% |
| Q4 FY2018 | Dec 31, 2018 | 53M | +53.6% |
| Q3 FY2018 | Sep 30, 2018 | 39M | -48.2% |
| Q2 FY2018 | Jun 30, 2018 | 38M | – |
| Q1 FY2018 | Mar 31, 2018 | 38M | – |
| Q2 FY2017 | Jun 30, 2017 | 34M | – |
| Q1 FY2017 | Mar 31, 2017 | 75M | – |
See a number that looks wrong?